/
We provide services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. Until recently, we were a holding company for IMAC Regeneration Centers, The BackSpace retail stores and our Investigational New Drug division, providing movement and orthopedic therapies and minimally invasive procedures to improve the physic…
The business is unprofitable at the operating level (-7804.67% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
ROIC dropped from -69.61% to -148.08%, capital efficiency is deteriorating. Negative free cash flow of -$4M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$72K
Net Income (TTM)
-$12M
▲ +4.0% YoY
Op. Margin
-7804.67%
ROIC
-174.08%
▼ -78.5pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$4M
Op. Cash Flow (TTM)
-$5M
▼ -13.3% YoY
Net Debt
$8M
Cash & Equiv.
$45K
5Y CAGR: -59.6%
Continue Research